Cites,Authors,Title,Year,Source,Publisher,ArticleURL,CitesURL,GSRank,QueryDate,Type,DOI,ISSN,CitationURL,Volume,Issue,StartPage,EndPage,ECC,CitesPerYear,CitesPerAuthor,AuthorCount,Age
622,"A Coxon, P Rieu, FJ Barkalow, S Askari, AH Sharpe…","A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation",1996,"Immunity","Elsevier","https://www.sciencedirect.com/science/article/pii/S1074761300802782","https://scholar.google.com/scholar?cites=2591025821616206021&as_sdt=800005&sciodt=0,15&hl=en",1,"2019-06-10","","","","",,,,,622,27.04,104,6,23
506,"J Oliner, H Min, J Leal, D Yu, S Rao, E You, X Tang…","Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2",2004,"Cancer cell","Elsevier","https://www.sciencedirect.com/science/article/pii/S1535610804002983","https://scholar.google.com/scholar?cites=9502476416438972814&as_sdt=800005&sciodt=0,15&hl=en",2,"2019-06-10","HTML","","","",,,,,506,33.73,63,8,15
309,"A Polverino, A Coxon, C Starnes, Z Diaz, T DeMelfi…","AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits …",2006,"Cancer research","AACR","http://cancerres.aacrjournals.org/content/66/17/8715.short","https://scholar.google.com/scholar?cites=14547945683013951461&as_sdt=800005&sciodt=0,15&hl=en",3,"2019-06-10","","","","",,,,,309,23.77,52,6,13
295,"T Burgess, A Coxon, S Meyer, J Sun, K Rex, T Tsuruda…","Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met–dependent human tumors",2006,"Cancer research","AACR","http://cancerres.aacrjournals.org/content/66/3/1721.short","https://scholar.google.com/scholar?cites=5787391232638494771&as_sdt=800005&sciodt=0,15&hl=en",4,"2019-06-10","","","","",,,,,295,22.69,42,7,13
242,"SG Soriano, A Coxon, YF Wang, MP Frosch…","Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury",1999,"Stroke","pdfs.semanticscholar.org","https://pdfs.semanticscholar.org/e0d5/383ae32adddfb82ca8352db8f59b2de4ad28.pdf","https://scholar.google.com/scholar?cites=15175227823212030660&as_sdt=800005&sciodt=0,15&hl=en",5,"2019-06-10","PDF","","","",,,,,242,12.10,48,5,20
219,"BL Falcón, H Hashizume, P Koumoutsakos…","Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels",2009,"The American journal of …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0002944010607249","https://scholar.google.com/scholar?cites=12686925350690180000&as_sdt=800005&sciodt=0,15&hl=en",6,"2019-06-10","HTML","","","",,,,,219,21.90,55,4,10
216,"H Hashizume, BL Falcón, T Kuroda, P Baluk, A Coxon…","Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth",2010,"Cancer research","AACR","http://cancerres.aacrjournals.org/content/70/6/2213.short","https://scholar.google.com/scholar?cites=451836782101233862&as_sdt=800005&sciodt=0,15&hl=en",7,"2019-06-10","","","","",,,,,216,24.00,36,6,9
208,"J Yan, V Větvička, Y Xia, A Coxon…","β-Glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18 …",1999,"The Journal of …","Am Assoc Immnol","http://www.jimmunol.org/content/163/6/3045.short","https://scholar.google.com/scholar?cites=252797756155689398&as_sdt=800005&sciodt=0,15&hl=en",8,"2019-06-10","","","","",,,,,208,10.40,42,5,20
179,"A Coxon, T Tang, TN Mayadas","Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo: a role for granulocyte/macrophage colony-stimulating factor",1999,"Journal of Experimental Medicine","jem.rupress.org","http://jem.rupress.org/content/190/7/923.abstract","https://scholar.google.com/scholar?cites=9158865819521194719&as_sdt=800005&sciodt=0,15&hl=en",9,"2019-06-10","","","","",,,,,179,8.95,60,3,20
175,"A Coxon, X Cullere, S Knight, S Sethi, MW Wakelin…","FcγRIII mediates neutrophil recruitment to immune complexes: a mechanism for neutrophil accumulation in immune-mediated inflammation",2001,"Immunity","Elsevier","https://www.sciencedirect.com/science/article/pii/S1074761301001509","https://scholar.google.com/scholar?cites=13563132765672593238&as_sdt=800005&sciodt=0,15&hl=en",10,"2019-06-10","HTML","","","",,,,,175,9.72,29,6,18
164,"MS Gordon, CJ Sweeney, DS Mendelson…","Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor–neutralizing monoclonal antibody, in a first-in-human study of …",2010,"Clinical Cancer …","AACR","http://clincancerres.aacrjournals.org/content/16/2/699.short","https://scholar.google.com/scholar?cites=16517748507207894193&as_sdt=800005&sciodt=0,15&hl=en",11,"2019-06-10","","","","",,,,,164,18.22,41,4,9
142,"HT Jun, J Sun, K Rex, R Radinsky, R Kendall…","AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and …",2007,"Clinical Cancer …","AACR","http://clincancerres.aacrjournals.org/content/13/22/6735.short","https://scholar.google.com/scholar?cites=9365102071819571129&as_sdt=800005&sciodt=0,15&hl=en",12,"2019-06-10","","","","",,,,,142,11.83,24,6,12
135,"AM Sinclair, A Coxon, I McCaffery, S Kaufman…","Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells",2010,"Blood","Am Soc Hematology","http://www.bloodjournal.org/content/115/21/4264.short","https://scholar.google.com/scholar?cites=12937394179631850093&as_sdt=800005&sciodt=0,15&hl=en",13,"2019-06-10","","","","",,,,,135,15.00,27,5,9
134,"SF Bellon, P Kaplan-Lefko, Y Yang, Y Zhang…","c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations",2008,"Journal of Biological …","ASBMB","http://www.jbc.org/content/283/5/2675.short","https://scholar.google.com/scholar?cites=6812739424404940217&as_sdt=800005&sciodt=0,15&hl=en",14,"2019-06-10","","","","",,,,,134,12.18,27,5,11
133,"A Coxon, K Maundrell, SE Kearsey","Fission yeast cdc21 + belongs to a family of proteins involved in an early step of chromosome replication",1992,"Nucleic acids research","academic.oup.com","https://academic.oup.com/nar/article-abstract/20/21/5571/2376653","https://scholar.google.com/scholar?cites=7678437479871582173&as_sdt=800005&sciodt=0,15&hl=en",15,"2019-06-10","","","","",,,,,133,4.93,44,3,27
128,"MH Potashman, J Bready, A Coxon…","Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors",2007,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm070034i","https://scholar.google.com/scholar?cites=4185332871755477827&as_sdt=800005&sciodt=0,15&hl=en",16,"2019-06-10","","","","",,,,,128,10.67,32,4,12
123,"A Coxon, J Bready, H Min, S Kaufman, J Leal…","Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2–neutralizing …",2010,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/9/10/2641.short","https://scholar.google.com/scholar?cites=13218971090398949711&as_sdt=800005&sciodt=0,15&hl=en",17,"2019-06-10","","","","",,,,,123,13.67,21,6,9
120,"TL Burgess, J Sun, S Meyer, TS Tsuruda, J Sun…","Biochemical characterization of AMG 102: a neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factor",2010,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/9/2/400.short","https://scholar.google.com/scholar?cites=5478958926962359947&as_sdt=800005&sciodt=0,15&hl=en",18,"2019-06-10","","","","",,,,,120,13.33,20,6,9
120,"AR Rosenkranz, A Coxon, M Maurer…","Cutting edge: impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice",1998,"The Journal of …","Am Assoc Immnol","http://www.jimmunol.org/content/161/12/6463.short","https://scholar.google.com/scholar?cites=7022213986184358434&as_sdt=800005&sciodt=0,15&hl=en",19,"2019-06-10","","","","",,,,,120,5.71,30,4,21
109,"ZM Dong, JC Gutierrez-Ramos…","A new class of obesity genes encodes leukocyte adhesion receptors",1997,"Proceedings of the …","National Acad Sciences","https://www.pnas.org/content/94/14/7526.short","https://scholar.google.com/scholar?cites=6407794806668076622&as_sdt=800005&sciodt=0,15&hl=en",20,"2019-06-10","","","","",,,,,109,4.95,36,3,22
97,"BL Hodous, SD Geuns-Meyer, PE Hughes…","Evolution of a highly selective and potent 2-(pyridin-2-yl)-1, 3, 5-triazine Tie-2 kinase inhibitor",2007,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm061107l","https://scholar.google.com/scholar?cites=363232138594537347&as_sdt=800005&sciodt=0,15&hl=en",21,"2019-06-10","","","","",,,,,97,8.08,24,4,12
98,"PJ Kaplan-Lefko, JD Graves, SJ Zoog…","Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types",2010,"Cancer biology & …","Taylor & Francis","https://www.tandfonline.com/doi/abs/10.4161/cbt.9.8.11264","https://scholar.google.com/scholar?cites=3733492579228480939&as_sdt=800005&sciodt=0,15&hl=en",22,"2019-06-10","","","","",,,,,98,10.89,25,4,9
92,"TH Bestor, A Coxon","Cytosine methylation The pros and cons of DNA methylation",1993,"Current Biology","cell.com","https://www.cell.com/current-biology/pdf/0960-9822(93)90209-7.pdf","https://scholar.google.com/scholar?cites=3596686234717328982&as_sdt=800005&sciodt=0,15&hl=en",23,"2019-06-10","","","","",,,,,92,3.54,46,2,26
89,"A Coxon, B Bolon, J Estrada, S Kaufman…","Inhibition of interleukin‐1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis",2002,"Arthritis & …","Wiley Online Library","https://onlinelibrary.wiley.com/doi/abs/10.1002/art.10546","https://scholar.google.com/scholar?cites=16919689974051485256&as_sdt=800005&sciodt=0,15&hl=en",24,"2019-06-10","","","","",,,,,89,5.24,18,5,17
84,"IJ Davis, AW McFadden, Y Zhang, A Coxon…","Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma",2010,"Cancer research","AACR","http://cancerres.aacrjournals.org/content/70/2/639.short","https://scholar.google.com/scholar?cites=600340800178031354&as_sdt=800005&sciodt=0,15&hl=en",25,"2019-06-10","","","","",,,,,84,9.33,17,5,9
74,"JC Harmange, MM Weiss, J Germain…","Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation",2008,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm701097z","https://scholar.google.com/scholar?cites=16496516184481175442&as_sdt=800005&sciodt=0,15&hl=en",26,"2019-06-10","","","","",,,,,74,6.73,19,4,11
76,"G Athauda, A Giubellino, JA Coleman, C Horak…","c-Met ectodomain shedding rate correlates with malignant potential",2006,"Clinical cancer …","AACR","http://clincancerres.aacrjournals.org/content/12/14/4154.short","https://scholar.google.com/scholar?cites=1884895852200402631&as_sdt=800005&sciodt=0,15&hl=en",27,"2019-06-10","","","","",,,,,76,5.85,15,5,13
71,"ND D'Angelo, SF Bellon, SK Booker…","Design, synthesis, and biological evaluation of potent c-Met inhibitors",2008,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm8006189","https://scholar.google.com/scholar?cites=5715865718913457328&as_sdt=800005&sciodt=0,15&hl=en",28,"2019-06-10","","","","",,,,,71,6.45,18,4,11
68,"Y Zhang, PJ Kaplan-Lefko, K Rex, Y Yang, J Moriguchi…","Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo",2008,"Cancer research","AACR","http://cancerres.aacrjournals.org/content/68/16/6680.short","https://scholar.google.com/scholar?cites=5510613738098721990&as_sdt=800005&sciodt=0,15&hl=en",29,"2019-06-10","","","","",,,,,68,6.18,11,6,11
64,"DS La, J Belzile, JV Bready, A Coxon…","Novel 2, 3-dihydro-1, 4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis",2008,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm701129j","https://scholar.google.com/scholar?cites=12023131233756165035&as_sdt=800005&sciodt=0,15&hl=en",30,"2019-06-10","","","","",,,,,64,5.82,13,5,11
52,"A Coxon, T Bush, D Saffran, S Kaufman…","Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor …",2009,"Clinical Cancer …","AACR","http://clincancerres.aacrjournals.org/content/15/1/110.short","https://scholar.google.com/scholar?cites=15628227006304663550&as_sdt=800005&sciodt=0,15&hl=en",31,"2019-06-10","","","","",,,,,52,5.20,10,5,10
50,"TL Burgess, A Coxon, LL Green, K Zhang","Specific binding agents to hepatocyte growth factor",2013,"US Patent 8,609,090","Google Patents","https://patents.google.com/patent/US8609090B2/en","https://scholar.google.com/scholar?cites=2398746775052622392&as_sdt=800005&sciodt=0,15&hl=en",32,"2019-06-10","","","","",,,,,50,8.33,13,4,6
50,"K Rex, S Jeffries, ML Brown, T Carlson, A Coxon…","Sphingosine kinase activity is not required for tumor cell viability",2013,"PLoS …","journals.plos.org","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0068328","https://scholar.google.com/scholar?cites=9155523998962794695&as_sdt=800005&sciodt=0,15&hl=en",33,"2019-06-10","HTML","","","",,,,,50,8.33,8,6,6
48,"DJ Gustin, Y Li, ML Brown, X Min, MJ Schmitt…","Structure guided design of a series of sphingosine kinase (SphK) inhibitors",2013,"Bioorganic & medicinal …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0960894X13007397","https://scholar.google.com/scholar?cites=7692031242088133547&as_sdt=800005&sciodt=0,15&hl=en",34,"2019-06-10","HTML","","","",,,,,48,8.00,8,6,6
42,"VJ Cee, BK Albrecht, S Geuns-Meyer…","Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase",2007,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm061112p","https://scholar.google.com/scholar?cites=18344182150520298737&as_sdt=800005&sciodt=0,15&hl=en",35,"2019-06-10","","","","",,,,,42,3.50,11,4,12
41,"CF Gao, Q Xie, YW Zhang, Y Su, P Zhao, B Cao…","Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth …",2009,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/8/10/2803.short","https://scholar.google.com/scholar?cites=17617998493219902887&as_sdt=800005&sciodt=0,15&hl=en",36,"2019-06-10","","","","",,,,,41,4.10,6,7,10
41,"MM Weiss, JC Harmange, AJ Polverino…","Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors",2008,"Journal of medicinal …","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/jm701098w","https://scholar.google.com/scholar?cites=5603584464039386282&as_sdt=800005&sciodt=0,15&hl=en",37,"2019-06-10","","","","",,,,,41,3.73,10,4,11
42,"VJ Cee, AC Cheng, K Romero, S Bellon, C Mohr…","Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase",2009,"Bioorganic & medicinal …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0960894X0801439X","https://scholar.google.com/scholar?cites=1162701109201379068&as_sdt=800005&sciodt=0,15&hl=en",38,"2019-06-10","HTML","","","",,,,,42,4.20,7,6,10
40,"J Canon, R Bryant, M Roudier, T Osgood, J Jones…","Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis",2010,"Bone","Elsevier","https://www.sciencedirect.com/science/article/pii/S8756328210004898","https://scholar.google.com/scholar?cites=12647525288744370966&as_sdt=800005&sciodt=0,15&hl=en",39,"2019-06-10","HTML","","","",,,,,40,4.44,7,6,9
36,"J Canon, T Osgood, SH Olson, AY Saiki…","The MDM2 inhibitor AMG 232 demonstrates robust antitumor efficacy and potentiates the activity of p53-inducing cytotoxic agents",2015,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/14/3/649.short","https://scholar.google.com/scholar?cites=10927318402383808610&as_sdt=800005&sciodt=0,15&hl=en",40,"2019-06-10","","","","",,,,,36,9.00,7,5,4
36,"EH van der Horst, BT Frank, L Chinn, A Coxon, S Li…","The growth factor Midkine antagonizes VEGF signaling in vitro and in vivo",2008,"Neoplasia","Elsevier","https://www.sciencedirect.com/science/article/pii/S1476558608800474","https://scholar.google.com/scholar?cites=13989466109243844459&as_sdt=800005&sciodt=0,15&hl=en",41,"2019-06-10","","","","",,,,,36,3.27,6,6,11
31,"A Coxon, TH Bestor","Proteins that glow in green and blue",1995,"Chemistry & biology","Elsevier","https://www.sciencedirect.com/science/article/pii/107455219590011X","https://scholar.google.com/scholar?cites=15266993447785916156&as_sdt=800005&sciodt=0,15&hl=en",42,"2019-06-10","","","","",,,,,31,1.29,16,2,24
28,"JD Oliner, J Bready, L Nguyen…","AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases",2012,"… & visual science","iovs.arvojournals.org","https://iovs.arvojournals.org/article.aspx?articleid=2188624","https://scholar.google.com/scholar?cites=5330355202875961741&as_sdt=800005&sciodt=0,15&hl=en",43,"2019-06-10","HTML","","","",,,,,28,4.00,7,4,7
27,"PE Hughes, K Rex, S Caenepeel, Y Yang…","In vitro and in vivo activity of AMG 337, a potent and selective MET kinase inhibitor, in MET-dependent cancer models",2016,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/15/7/1568.abstract","https://scholar.google.com/scholar?cites=18377365780084063433&as_sdt=800005&sciodt=0,15&hl=en",44,"2019-06-10","","","","",,,,,27,9.00,5,5,3
24,"C Dominguez, L Smith, Q Huang, C Yuan…","Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr",2007,"Bioorganic & medicinal …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0960894X07008657","https://scholar.google.com/scholar?cites=6926921377501476495&as_sdt=800005&sciodt=0,15&hl=en",45,"2019-06-10","HTML","","","",,,,,24,2.00,5,5,12
22,"L Zhang, S Virani, Y Zhang, MS Bhojani…","Molecular imaging of c-Met tyrosine kinase activity",2011,"Analytical …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0003269711000558","https://scholar.google.com/scholar?cites=5877336709569759164&as_sdt=800005&sciodt=0,15&hl=en",46,"2019-06-10","HTML","","","",,,,,22,2.75,4,5,8
21,"TJ Kruser, DL Wheeler, EA Armstrong, M Iida…","Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors",2010,"Clinical Cancer …","AACR","http://clincancerres.aacrjournals.org/content/16/14/3639.short","https://scholar.google.com/scholar?cites=17525763569949031079&as_sdt=800005&sciodt=0,15&hl=en",47,"2019-06-10","","","","",,,,,21,2.33,4,5,9
24,"H Zheng, Y Bae, S Kasimir-Bauer, R Tang, J Chen…","Therapeutic antibody targeting tumor-and osteoblastic niche-derived Jagged1 sensitizes bone metastasis to chemotherapy",2017,"Cancer cell","Elsevier","https://www.sciencedirect.com/science/article/pii/S1535610817304725","https://scholar.google.com/scholar?cites=5829397358200960096&as_sdt=800005&sciodt=0,15&hl=en",48,"2019-06-10","HTML","","","",,,,,24,12.00,4,6,2
19,"D Bauer, DA Whittington, A Coxon, J Bready…","Evaluation of indazole-based compounds as a new class of potent KDR/VEGFR-2 inhibitors",2008,"Bioorganic & medicinal …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0960894X0800869X","https://scholar.google.com/scholar?cites=17599734386523993772&as_sdt=800005&sciodt=0,15&hl=en",49,"2019-06-10","HTML","","","",,,,,19,1.73,4,5,11
18,"A Coxon, B Ziegler, S Kaufman…","Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models",2012,"Molecular …","molecular-cancer.biomedcentral …","https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-11-70","https://scholar.google.com/scholar?cites=2040381154297103498&as_sdt=800005&sciodt=0,15&hl=en",50,"2019-06-10","HTML","","","",,,,,18,2.57,5,4,7
19,"X Wang, AJ Bullock, L Zhang, L Wei, D Yu…","The role of angiopoietins as potential therapeutic targets in renal cell carcinoma",2014,"Translational …","Elsevier","https://www.sciencedirect.com/science/article/pii/S1936523314000047","https://scholar.google.com/scholar?cites=17921550965575238371&as_sdt=800005&sciodt=0,15&hl=en",51,"2019-06-10","HTML","","","",,,,,19,3.80,3,6,5
19,"TL Burgess, A Coxon, I Dussault…","Combinations vegf (r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer",2011,"US Patent App. 12 …","Google Patents","https://patents.google.com/patent/US20110104161A1/en","https://scholar.google.com/scholar?cites=9138913222178318796&as_sdt=800005&sciodt=0,15&hl=en",52,"2019-06-10","","","","",,,,,19,2.38,5,4,8
15,"A Coxon, K Rex, S Meyer, J Sun, J Sun, Q Chen…","Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met–dependent tumors in animal models",2009,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/8/5/1119.short","https://scholar.google.com/scholar?cites=16044848610686784600&as_sdt=800005&sciodt=0,15&hl=en",53,"2019-06-10","","","","",,,,,15,1.50,2,7,10
13,"I Dussault, P Kaplan-Lefko, HT Jun, A Coxon…","HGF-and c-Met-targeted drugs: hopes, challenges and their future in cancer therapy",2006,"Drugs …","journals.prous.com","https://journals.prous.com/journals/servlet/xmlxsl/dof/20063109/pdf/df310819.pdf%3Fp_JournalId%3D2&p_refId%3D1026670&p_IsPs%3DN","https://scholar.google.com/scholar?cites=11068548441544627325&as_sdt=800005&sciodt=0,15&hl=en",54,"2019-06-10","","","","",,,,,13,1.00,3,5,13
11,"AA Boezio, KW Copeland, K Rex, B K. Albrecht…","Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a …",2016,"","ACS Publications","https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01716","https://scholar.google.com/scholar?cites=1258898672202201361&as_sdt=800005&sciodt=0,15&hl=en",55,"2019-06-10","","","","",,,,,11,3.67,2,5,3
16,"SL Ross, M Sherman, PL McElroy, JA Lofgren…","Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing",2017,"PloS one","journals.plos.org","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183390","https://scholar.google.com/scholar?cites=12354042570964896291&as_sdt=800005&sciodt=0,15&hl=en",56,"2019-06-10","HTML","","","",,,,,16,8.00,3,5,2
11,"C de Zafra, M Balazs, F Fajardo, L Liang, W Zhong…","Preclinical characterization of AMG 424, a novel humanized T cell-recruiting bispecific anti-CD3/CD38 antibody",2017,"","Am Soc Hematology","http://www.bloodjournal.org/content/130/Suppl_1/500.abstract","https://scholar.google.com/scholar?cites=66793579201752594&as_sdt=800005&sciodt=0,15&hl=en",57,"2019-06-10","","","","",,,,,11,5.50,2,6,2
20,"S Caenepeel, SP Brown, B Belmontes, G Moody…","AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies",2018,"Cancer discovery","AACR","http://cancerdiscovery.aacrjournals.org/content/8/12/1582.abstract","https://scholar.google.com/scholar?cites=14673030979088924228&as_sdt=800005&sciodt=0,15&hl=en",58,"2019-06-10","HTML","","","",,,,,20,20.00,4,5,1
10,"Z Du, S Caenepeel, Y Shen, K Rex, Y Zhang…","Preclinical evaluation of AMG 337, a highly selective small molecule MET inhibitor, in hepatocellular carcinoma",2016,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/15/6/1227.short","https://scholar.google.com/scholar?cites=1770147335216144560&as_sdt=800005&sciodt=0,15&hl=en",59,"2019-06-10","","","","",,,,,10,3.33,2,6,3
11,"S Caenepeel, K Cooke, S Wadsworth, G Huang…","MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor",2017,"Oncotarget","ncbi.nlm.nih.gov","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392287/","https://scholar.google.com/scholar?cites=5022767323866386150&as_sdt=800005&sciodt=0,15&hl=en",60,"2019-06-10","HTML","","","",,,,,11,5.50,2,5,2
11,"SR Caenepeel, B Belmontes, J Sun, A Coxon…","Preclinical evaluation of AMG 176, a novel, potent and selective Mcl-1 inhibitor with robust anti-tumor activity in Mcl-1 dependent cancer models",2017,"","AACR","http://cancerres.aacrjournals.org/content/77/13_Supplement/2027.short","https://scholar.google.com/scholar?cites=10057026957628173529&as_sdt=800005&sciodt=0,15&hl=en",61,"2019-06-10","","","","",,,,,11,5.50,2,5,2
8,"K Rex, XZ Lewis, S Gobalakrishnan, C Glaus…","Evaluation of the antitumor effects of rilotumumab by PET imaging in a U-87 MG mouse xenograft model",2013,"Nuclear medicine and …","Elsevier","https://www.sciencedirect.com/science/article/pii/S0969805113000073","https://scholar.google.com/scholar?cites=7301795400935744553&as_sdt=800005&sciodt=0,15&hl=en",62,"2019-06-10","HTML","","","",,,,,8,1.33,2,5,6
7,"A Coxon, K Rex, JR Sun, T Osgood, J Leal, S Kaufman…","Combined treatment of angiopoietin and VEGF pathway antagonists enhances antitumor activity in preclinical models of colon carcinoma",2008,"","AACR","http://cancerres.aacrjournals.org/content/68/9_Supplement/1113.short","https://scholar.google.com/scholar?cites=8830858686277842957&as_sdt=800005&sciodt=0,15&hl=en",63,"2019-06-10","","","","",,,,,7,0.64,1,7,11
6,"PE Hughes, Y Yang, K Rex, Y Zhang, PJ Kaplan-Lefko…","AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models",2014,"","AACR","http://cancerres.aacrjournals.org/content/74/19_Supplement/728.short","https://scholar.google.com/scholar?cites=18172916407138225330&as_sdt=800005&sciodt=0,15&hl=en",64,"2019-06-10","","","","",,,,,6,1.20,1,6,5
6,"S Jeffries, ML Brown, T Carlson, A Coxon, F Fajardo…","Vivienne; Wickramasinghe, Dineli; Wong, Mariwil; Xu, Guifen; Wesche, Holger",2013,"PLoS One","","","https://scholar.google.com/scholar?cites=4405100486759378293&as_sdt=800005&sciodt=0,15&hl=en",65,"2019-06-10","CITATION","","","",,,,,6,1.00,1,6,6
5,"P Kaplan-Lefko, T Bush, B Belmontes, J Moriguchi…","AMG 655, a fully human agonistic antibody against death receptor 5, enhances the anti-tumor activity of gemcitabine in MiaPaCa2/T2, a pancreatic cancer model",2008,"","AACR","http://cancerres.aacrjournals.org/content/68/9_Supplement/3999.short","https://scholar.google.com/scholar?cites=11733184183544634086&as_sdt=800005&sciodt=0,15&hl=en",66,"2019-06-10","","","","",,,,,5,0.45,1,5,11
7,"G Lorenczewski, M Friedrich, R Kischel, C Dahlhoff…","Generation of a half-life extended anti-CD19 BiTE® antibody construct compatible with once-weekly dosing for treatment of CD19-positive malignancies",2017,"","Am Soc Hematology","http://www.bloodjournal.org/content/130/suppl_1/2815.abstract","https://scholar.google.com/scholar?cites=15145269511057855556&as_sdt=800005&sciodt=0,15&hl=en",67,"2019-06-10","","","","",,,,,7,3.50,1,5,2
4,"CNAM van den Heuvel, AC Navis, T de Bitter…","Selective MET kinase inhibition in MET-dependent glioma models alters gene expression and induces tumor plasticity",2017,"Molecular Cancer …","AACR","http://mcr.aacrjournals.org/content/15/11/1587.abstract","https://scholar.google.com/scholar?cites=8911890133700666920&as_sdt=800005&sciodt=0,15&hl=en",68,"2019-06-10","","","","",,,,,4,2.00,1,4,2
4,"P Kaplan-Lefko, Y Gan, J Huard, M Colloton, S Zoog…","AMG 655, a fully human agonistic antibody against TRAIL receptor-2, induces apoptosis via caspase activation in vitro and in vivo",2007,"","AACR","http://cancerres.aacrjournals.org/content/67/9_Supplement/4867.short","https://scholar.google.com/scholar?cites=13614560478398984413&as_sdt=800005&sciodt=0,15&hl=en",69,"2019-06-10","","","","",,,,,4,0.33,1,6,12
4,"S Kaufman, C Starnes, A Coxon, V Patel, A Tasker…","AMG 706 induces the rapid destruction of tumor microvessels in nude mice",2006,"","AACR","http://cancerres.aacrjournals.org/content/66/8_Supplement/892.1.short","https://scholar.google.com/scholar?cites=6017015247519523894&as_sdt=800005&sciodt=0,15&hl=en",70,"2019-06-10","","","","",,,,,4,0.31,1,6,13
3,"J Canon, R Bryant, R Miller…","P13. The RANKL inhibitor OPG-Fc delays the de novo establishment of breast cancer skeletal metastases in an MDA-MB-231 mouse model",2008,"Cancer …","cancertreatmentreviews.com","https://www.cancertreatmentreviews.com/article/S0305-7372(08)00098-4/abstract","https://scholar.google.com/scholar?cites=17672864746374481027&as_sdt=800005&sciodt=0,15&hl=en",71,"2019-06-10","","","","",,,,,3,0.27,1,4,11
3,"M Boedighiemer, DJ Freeman, D Fitzpatrick, M Damore…","Gene expression profiles can predict panitumumab monotherapy responsiveness in xenograft models: A 'balanced'approach.",2005,"","AACR","http://cancerres.aacrjournals.org/content/65/9_Supplement/1.1.short","https://scholar.google.com/scholar?cites=15850085419884990134&as_sdt=800005&sciodt=0,15&hl=en",72,"2019-06-10","","","","",,,,,3,0.21,1,5,14
4,"V Nangia, FM Siddiqui, S Caenepeel, D Timonina…","Exploiting MCL1 Dependency with Combination MEK+ MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non–Small Cell Lung …",2018,"Cancer discovery","AACR","http://cancerdiscovery.aacrjournals.org/content/8/12/1598.abstract","https://scholar.google.com/scholar?cites=13931915350111558438&as_sdt=800005&sciodt=0,15&hl=en",73,"2019-06-10","","","","",,,,,4,4.00,1,5,1
4,"A Goyos, CM Li, P Deegen, P Bogner, O Thomas…","Generation of half-life extended anti-BCMA Bite® antibody construct compatible with once-weekly dosing for treatment of multiple myeloma (MM)",2017,"","Am Soc Hematology","http://www.bloodjournal.org/content/130/suppl_1/5389.abstract","https://scholar.google.com/scholar?cites=373849898326412573&as_sdt=800005&sciodt=0,15&hl=en",74,"2019-06-10","","","","",,,,,4,2.00,1,6,2
3,"CO Starnes, A Coxon, S Scully, D Freeman, V Patel…","Antitumor activity of AMG 706 alone and in combination with chemotherapy against established human tumor xenograft models in nude mice",2006,"","AACR","http://cancerres.aacrjournals.org/content/66/8_Supplement/889.2.short","https://scholar.google.com/scholar?cites=5228854356822074308&as_sdt=800005&sciodt=0,15&hl=en",75,"2019-06-10","","","","",,,,,3,0.23,1,6,13
3,"TL Arvedson, M Balazs, P Bogner, K Black, K Graham…","Generation of half-life extended anti-CD33 BiTE® antibody constructs compatible with once-weekly dosing",2017,"","AACR","http://cancerres.aacrjournals.org/content/77/13_Supplement/55.short","https://scholar.google.com/scholar?cites=11947150558034589270&as_sdt=800005&sciodt=0,15&hl=en",76,"2019-06-10","","","","",,,,,3,1.50,1,6,2
2,"A Coxon, K Rex, J Sun, J Moriguchi, J Malella, M Ma…","Exploratory biomarkers in the HGF/SF: c-Met axis: preclinical and clinical results",2008,"","AACR","http://cancerres.aacrjournals.org/content/68/9_Supplement/2804.short","https://scholar.google.com/scholar?cites=9901670602705422317&as_sdt=800005&sciodt=0,15&hl=en",77,"2019-06-10","","","","",,,,,2,0.18,0,7,11
2,"O Kalous, D Conklin, K Manivong, W Wayne…","Preclinical characterization of AMG 900, a pan-aurora kinase inhibitor, alone and in combination with taxanes in ovarian cancer",2016,"","AACR","http://cancerres.aacrjournals.org/content/76/14_Supplement/3008.short","https://scholar.google.com/scholar?cites=3041506790861696465&as_sdt=800005&sciodt=0,15&hl=en",78,"2019-06-10","","","","",,,,,2,0.67,0,5,3
2,"Y Zhang, P Kaplan-Lefko, K Rex, Y Yang, J Moriguchi…","Identification and characterization of a novel RON/c-Met small molecule inhibitor",2007,"","AACR","http://mct.aacrjournals.org/content/6/11_Supplement/A223.short","https://scholar.google.com/scholar?cites=16818152840305543140&as_sdt=800005&sciodt=0,15&hl=en",79,"2019-06-10","","","","",,,,,2,0.17,0,6,12
2,"A Coxon, J Bready, P Hughes, J Estrada, L Wang…","Motesanib diphosphate (AMG 706) inhibits the growth of medullary thyroid carcinoma in a nude mouse model",2007,"","AACR","http://cancerres.aacrjournals.org/content/67/9_Supplement/LB-283.short","https://scholar.google.com/scholar?cites=15803997683496485077&as_sdt=800005&sciodt=0,15&hl=en",80,"2019-06-10","","","","",,,,,2,0.17,0,6,12
1,"A Coxon, A Sinclair, I Archibeque, J Estrada…","Endothelial Cells Express No Detectable Erythropoietin Receptor Protein and Erythropoietin Does Not Induce Angiogenesis In Vivo.",2007,"","Am Soc Hematology","http://www.bloodjournal.org/content/110/11/4077.abstract","https://scholar.google.com/scholar?cites=14878574987798991074&as_sdt=800005&sciodt=0,15&hl=en",81,"2019-06-10","","","","",,,,,1,0.08,0,5,12
1,"A Coxon, AA Chabot, SC Lougheed, JA Dávila…","Characterization of 17 microsatellite loci for use in population genetic and mating system studies of the endangered North American passerine, loggerhead …",2012,"Conservation genetics …","Springer","https://link.springer.com/article/10.1007/s12686-011-9585-2","https://scholar.google.com/scholar?cites=11038064731295200854&as_sdt=800005&sciodt=0,15&hl=en",82,"2019-06-10","HTML","","","",,,,,1,0.14,0,5,7
1,"S Bellon, P Kaplan-Lefko, Y Zhang, Y Yang…","c-Met inhibitors with novel binding mode show activity against several HPRCC-related mutations",2007,"","AACR","http://cancerres.aacrjournals.org/content/67/9_Supplement/3162.short","https://scholar.google.com/scholar?cites=2355085664450715127&as_sdt=800005&sciodt=0,15&hl=en",83,"2019-06-10","","","","",,,,,1,0.08,0,5,12
1,"A Coxon, C Starnes, J Bready, J Estrada, S Kaufman…","The effect of AMG 706, a novel multi-kinase inhibitor, on angiogenesis and tumor growth in preclinical models",2006,"","AACR","http://cancerres.aacrjournals.org/content/66/8_Supplement/889.1.short","https://scholar.google.com/scholar?cites=15291809704599473004&as_sdt=800005&sciodt=0,15&hl=en",84,"2019-06-10","","","","",,,,,1,0.08,0,6,13
1,"B Ziegler, S Kaufman, M Xu, H Wang, D Weischun…","Antitumor activity of motesanib alone and in combination with chemotherapy in xenograft models of human non-small cell lung cancer",2010,"","AACR","http://cancerres.aacrjournals.org/content/70/8_Supplement/1380.short","https://scholar.google.com/scholar?cites=11972956997814655298&as_sdt=800005&sciodt=0,15&hl=en",85,"2019-06-10","","","","",,,,,1,0.11,0,6,9
1,"JV Bready, K Lee, R Jacobsen, K Graham, J Estrada…","Development and preclinical testing of AMG 780, a fully human antibody targeting angiopoietin 1 (Ang1) and angiopoietin 2 (Ang2)",2014,"","AACR","http://cancerres.aacrjournals.org/content/74/19_Supplement/1022.short","https://scholar.google.com/scholar?cites=17401523294790774709&as_sdt=800005&sciodt=0,15&hl=en",86,"2019-06-10","","","","",,,,,1,0.20,0,6,5
1,"TL Arvedson, L Tran, SL Ross, S Yoder, A Hertz…","Fetal hemoglobin expression is differentially affected by inhibition of the proposed dred complex constituents, LSD1 and DNMT1",2012,"","Am Soc Hematology","http://www.bloodjournal.org/content/120/21/3263?sso-checked=true&utm_source=TrendMD&utm_medium=cpc&utm_campaign=Blood_TrendMD_0","https://scholar.google.com/scholar?cites=13866235361805438746&as_sdt=800005&sciodt=0,15&hl=en",87,"2019-06-10","","","","",,,,,1,0.14,0,6,7
1,"M Payton, T Jun, W Wayne, D Yu, R Manoukian…","Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method",2014,"Laboratory …","nature.com","https://www.nature.com/articles/doi:10.1038%2Flabinvest.2014.116","https://scholar.google.com/scholar?cites=2951034772008371369&as_sdt=800005&sciodt=0,15&hl=en",88,"2019-06-10","","","","",,,,,1,0.20,0,6,5
1,"A Coxon, P Kaplan-Lefko…","Inhibition of angiopoietin and Dll4 signaling in the tumor vasculature leads to increased efficacy in mouse tumor xenograft models",2012,"CANCER …","AMER ASSOC CANCER …","","https://scholar.google.com/scholar?cites=17080188008120280186&as_sdt=800005&sciodt=0,15&hl=en",89,"2019-06-10","CITATION","","","",,,,,1,0.14,0,3,7
1,"A Coxon, T Bush, B Belmontes, D Saffran…","Anti-tumor activity of motesanib diphosphate alone and in combination with docetaxel or tamoxifen in xenograft models of human breast carcinoma",2007,"… Cancer Research and …","insights.ovid.com","https://insights.ovid.com/breast-cancer-research-treatment/bcart/2007/12/001/anti-tumor-activity-motesanib-diphosphate-alone/212/00001803","https://scholar.google.com/scholar?cites=15105317597222278294&as_sdt=800005&sciodt=0,15&hl=en",90,"2019-06-10","CITATION","","","",,,,,1,0.08,0,5,12
1,"K Cheung, G Juan, W Wayne, K Hanestad, K Keegan…","AMG 900, a potent and highly selective aurora kinase inhibitor shows promising preclinical activity against acute myeloid leukemia cell lines in vitro and in vivo",2013,"","Am Soc Hematology","http://www.bloodjournal.org/content/122/21/3823?variant=short","https://scholar.google.com/scholar?cites=10276383611820407348&as_sdt=800005&sciodt=0,15&hl=en",91,"2019-06-10","","","","",,,,,1,0.17,0,6,6
1,"S Caenepeel, E Cajulis, R Kendall, A Coxon, P Hughes","Targeting HGF-mediated resistance to vemurafenib in V600E BRAF mutant melanoma cell lines.",2013,"","AACR","http://cancerres.aacrjournals.org/content/73/8_Supplement/3405.short","https://scholar.google.com/scholar?cites=17848930624371349170&as_sdt=800005&sciodt=0,15&hl=en",92,"2019-06-10","","","","",,,,,1,0.17,0,5,6
1,"A Coxon, B Bolon, J Estrada, S Kaufman…","Differential Control Of Angiogenesis By Anakinra (il-1ra) And Peg stnf-ri.",2001,"Arthritis & …","insights.ovid.com","https://insights.ovid.com/arthritis-rheumatism/arhe/2001/09/001/differential-control-angiogenesis-anakinra-il-1ra/1201/00000889","https://scholar.google.com/scholar?cites=6524604618093364091&as_sdt=800005&sciodt=0,15&hl=en",93,"2019-06-10","CITATION","","","",,,,,1,0.06,0,5,18
1,"B Mattson, J Moriguchi, HT Jun, A Coxon, D Cordover…","Triple combination of bevacizumab, anti-DLL4 (delta like ligand 4) and trebananib gives enhanced therapeutic effects in three xenograft tumor models",2014,"","AACR","http://cancerres.aacrjournals.org/content/74/19_Supplement/2991.short","https://scholar.google.com/scholar?cites=10094334624436792064&as_sdt=800005&sciodt=0,15&hl=en",94,"2019-06-10","","","","",,,,,1,0.20,0,6,5
1,"J Estrada, S Kaufman, E Hurh, D Freeman, R Kendall…","Abstract# 140: Assessment of angiogenesis inhibitors in the retinopathy of prematurity model in mice",2009,"","AACR","http://cancerres.aacrjournals.org/content/69/9_Supplement/140.short","https://scholar.google.com/scholar?cites=13529373816336206349&as_sdt=800005&sciodt=0,15&hl=en",95,"2019-06-10","","","","",,,,,1,0.10,0,6,10
1,"SR Caenepeel, T Osgood, B Belmontes, J Sun…","Combined inhibition of MCL1 and BCL-2 with AMG 176 and venetoclax induces anti-tumor effects in primary patient samples and models of acute myeloid leukemia",2018,"","AACR","http://cancerres.aacrjournals.org/content/78/13_Supplement/3972.short","https://scholar.google.com/scholar?cites=3275853573239584830&as_sdt=800005&sciodt=0,15&hl=en",96,"2019-06-10","","","","",,,,,1,1.00,0,5,1
1,"AN Hata, FM Siddiqui, M Gomez-Caraballo, SJ Bilton…","Combined targeting of MEK and MCL-1 induces apoptosis and tumor regression of KRAS mutant NSCLC",2017,"","AACR","http://cancerres.aacrjournals.org/content/77/13_Supplement/2163.short","https://scholar.google.com/scholar?cites=15753681201244285516&as_sdt=800005&sciodt=0,15&hl=en",97,"2019-06-10","","","","",,,,,1,0.50,0,5,2
0,"A Coxon, T Bush, B Belmontes, D Saffran, V Ona…","Anti-tumor efficacy of AMG 706 in xenograft models of luminal, mesenchymal and basal human breast carcinoma",2007,"","AACR","http://cancerres.aacrjournals.org/content/67/9_Supplement/2133.short","",98,"2019-06-10","","","","",,,,,0,0.00,0,6,12
0,"A Goyos, CM Li, P Deegen, P Bogner, O Thomas…","Abstract LB-299: Cynomolgus monkey plasma cell gene signature to quantify the in vivo activity of a half-life extended anti-BCMA BiTE® for the treatment of multiple …",2018,"","AACR","http://cancerres.aacrjournals.org/content/78/13_Supplement/LB-299.short","",99,"2019-06-10","","","","",,,,,0,0.00,0,6,1
0,"F Cecchi, K Rex, J Schmidt, D Baker, MA Damore…","Abstract A204: A cellular model of acquired resistance to rilotumumab (AMG 102) in glioblastoma.",2011,"","AACR","http://mct.aacrjournals.org/content/10/11_Supplement/A204.short","",100,"2019-06-10","","","","",,,,,0,0.00,0,6,8
0,"H Wesche, ML Brown, TJ Carlson, A Coxon, B Frank…","Abstract LB-39: Sphingosine kinase activity is not required for tumor cell viability.",2013,"","AACR","http://cancerres.aacrjournals.org/content/73/8_Supplement/LB-39.short","",101,"2019-06-10","","","","",,,,,0,0.00,0,6,6
0,"J Estrada, S Ungersma, S Kaufman, B Yerby, N Zhang…","AMG 511, a potent and selective class I PI3K inhibitor, suppresses the growth of Kras mutant lung tumors in mice",2012,"","AACR","http://cancerres.aacrjournals.org/content/72/8_Supplement/980.short","",102,"2019-06-10","","","","",,,,,0,0.00,0,6,7
0,"A Coxon, P Kaplan-Lefko, S Kaufman, J Moriguchi…","Abstract LB-311: Inhibition of angiopoietin and Dll4 signaling in the tumor vasculature leads to increased efficacy in mouse tumor xenograft models",2012,"","AACR","http://cancerres.aacrjournals.org/content/72/8_Supplement/LB-311.short","",103,"2019-06-10","","","","",,,,,0,0.00,0,5,7
0,"X Wang, A Bullock, L Zhang, D Yu, L Wei, J Song…","Angiopoietin 2 is elevated in patients with RCC, and Ang2 inhibition improves antiantiogenic activity of sunitinib in a mouse model of RCC.",2013,"","AACR","http://cancerres.aacrjournals.org/content/73/8_Supplement/1608.short","",104,"2019-06-10","","","","",,,,,0,0.00,0,7,6
0,"A Coxon, C Starnes, J Bready, J Estrada, S Kaufman…","Inhibition of angiogenesis and xenograft tumor growth by AMG 273 a novel multi-kinase inhibitor",2007,"","AACR","http://cancerres.aacrjournals.org/content/67/9_Supplement/2134.short","",105,"2019-06-10","","","","",,,,,0,0.00,0,6,12
0,"JV Bready, P Kaplan-Lefko, J Moriguchi, M Payton…","Combined treatment of trebananib (AMG 386) with panitumumab in preclinical tumor models.",2013,"","AACR","http://cancerres.aacrjournals.org/content/73/8_Supplement/5089.short","",106,"2019-06-10","","","","",,,,,0,0.00,0,5,6
0,"JC Harmange, M Bajpai, D Bauer, S Bellon, G Borg…","Discovery, synthesis and optimization of a new class of potent KDR inhibitors: naphthoylamides",2006,"","AACR","http://cancerres.aacrjournals.org/content/66/8_Supplement/264.2.short","",107,"2019-06-10","","","","",,,,,0,0.00,0,6,13
0,"TL Burgess, A Coxon, I Dussault…","Combinations vegf (r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer",2014,"US Patent App. 14 …","Google Patents","https://patents.google.com/patent/US20140243339A1/en","",108,"2019-06-10","","","","",,,,,0,0.00,0,4,5
0,"TL Burgess, A Coxon, LL Green…","Specific binding agents to hepatocyte growth factor",2014,"US Patent App. 14 …","Google Patents","https://patents.google.com/patent/US20140154243A1/en","",109,"2019-06-10","","","","",,,,,0,0.00,0,4,5
0,"A Coxon","Analysis of the cdc21'+ gene of Schizosaccharomyces pombe.",1992,"","ethos.bl.uk","https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.305370","",110,"2019-06-10","CITATION","","","",,,,,0,0.00,0,1,27
0,"K Cooke, G Huang, S Caenepeel, H Ma, C Plewa…","HGF mediated resistance to BRAF inhibition in BRAF V600E mutant melanoma xenograft models",2014,"","AACR","http://cancerres.aacrjournals.org/content/74/19_Supplement/3712.short","",111,"2019-06-10","","","","",,,,,0,0.00,0,6,5
0,"SL Ross, M Mulen, PL McElroy, J Lofgren, G Moody…","Abstract LB-232: BiTE antibody constructs can mediate bystander tumor cell killing",2015,"","AACR","http://cancerres.aacrjournals.org/content/75/15_Supplement/LB-232.short","",112,"2019-06-10","","","","",,,,,0,0.00,0,6,4
0,"C Sastri, M Balazs, P Koppikar, JR Lipford, A Coxon…","Evaluation of soluble FLT3 ligand as a marker of bone marrow stress and recovery",2016,"","AACR","http://cancerres.aacrjournals.org/content/76/14_Supplement/494.short","",113,"2019-06-10","","","","",,,,,0,0.00,0,6,3
0,"J Bailis, P Deegen, O Thomas, P Bogner, J Wahl…","Preclinical evaluation of AMG 160, a next-generation bispecific T cell engager (BiTE) targeting the prostate-specific membrane antigen PSMA for metastatic castration …",2019,"","ascopubs.org","https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.7_suppl.301","",114,"2019-06-10","","","","",,,,,0,0.00,0,6,1
0,"M Payton, HK Cheung, MSS Ninniri, C Marinaccio…","Dual targeting of aurora kinases with AMG 900 exhibits potent preclinical activity against acute myeloid leukemia with distinct post-mitotic outcomes",2018,"Molecular cancer …","AACR","http://mct.aacrjournals.org/content/17/12/2575.abstract","",115,"2019-06-10","HTML","","","",,,,,0,0.00,0,5,1
0,"R Goldstein, A Henn, P Koppikar, I Archibeque, B Frank…","Evaluation of a FLT3 Bite® for Acute Myeloid Leukemia",2017,"","Am Soc Hematology","http://www.bloodjournal.org/content/130/Suppl_1/1354.abstract","",116,"2019-06-10","","","","",,,,,0,0.00,0,6,2
0,"F Cecchi, K Rex, J Schmidt, D Baker, MA Damore…","A cellular model of acquired resistance to rilotumumab (AMG 102) in glioblastoma.",2013,"","AACR","http://cancerres.aacrjournals.org/content/73/8_Supplement/5637.short","",117,"2019-06-10","","","","",,,,,0,0.00,0,6,6
0,"A Coxon, A Sinclair, I Archibeque…","Enclothelial cells express no detectable erythropoietin receptor protein and erythropoietin does not induce angiogenesis in vivo",2007,"…","… 1900 M STREET. NW SUITE 200 …","","",118,"2019-06-10","CITATION","","","",,,,,0,0.00,0,4,12
0,"MD Silva, B Yerby, J Moriguchi, A Gomez…","Response-Derived Input Function Estimation for Dynamic Contrast-Enhanced MRI Demonstrated by Anti-DLL4 Treatment in a Murine U87 Xenograft Model",2017,"Molecular Imaging and …","Springer","https://link.springer.com/article/10.1007/s11307-017-1065-y","",119,"2019-06-10","HTML","","","",,,,,0,0.00,0,5,2
0,"C van den Heuvel, A Navis, H Amiri, K Verrijp…","Selective MET kinase inhibition in MET-dependent glioma models",2017,"","AACR","http://cancerres.aacrjournals.org/content/77/13_Supplement/2077.short","",120,"2019-06-10","","","","",,,,,0,0.00,0,5,2
0,"J Canon, R Bryant, R Miller, R Erwert, M Roudier…","P12. Poster Withdrawn",,"cancertreatmentreviews.com","","https://www.cancertreatmentreviews.com/article/S0305-7372(08)00097-2/abstract","",121,"2019-06-10","CITATION","","","",,,,,0,0.00,0,6,
0,"A Coxon, K Rex, S Meyer, J Sun, J Sun, Q Chen…","The effect of a soluble c-Met receptor on phosphorylation of c-Met and tumor growth in preclinical models",2007,"","AACR","http://cancerres.aacrjournals.org/content/67/9_Supplement/2087A.short","",122,"2019-06-10","","","","",,,,,0,0.00,0,7,12
0,"A Sternjak, F Lee, J Wahl, D Rock, O Thomas…","Preclinical evaluation of a BiTE® antibody construct with extended half-life that targets the tumor differentiation marker mesothelin",2017,"","AACR","http://cancerres.aacrjournals.org/content/77/13_Supplement/3630.short","",123,"2019-06-10","","","","",,,,,0,0.00,0,6,2
0,"Z Du, S Caenepeel, Y Shen, K Rex, Y Zhang, ET Tang…","Preclinical evaluation of AMG 337, a highly selective small molecule MET inhibitor, in hepatocellular carcinoma",2015,"","AACR","http://cancerres.aacrjournals.org/content/75/15_Supplement/5391.short","",124,"2019-06-10","","","","",,,,,0,0.00,0,7,4
0,"T Kruser, D Wheeler, S Huang, E Armstrong, A Coxon…","Modulation of radiation response by motesanib diphosphate in models of head and neck squamous cell carcinoma",2008,"","AACR","http://cancerres.aacrjournals.org/content/68/9_Supplement/5764.short","",125,"2019-06-10","","","","",,,,,0,0.00,0,6,11
0,"C Dominguez, Q Huang, L Smith, C Yuan, L Cai, J Kim…","KDR inhibitors: From in vitro potency to in vivo efficacy",2006,"","AACR","http://cancerres.aacrjournals.org/content/66/8_Supplement/267.5.short","",126,"2019-06-10","","","","",,,,,0,0.00,0,7,13
0,"A Sinclair, A Coxon, I Archibeque, J Bready, J Estrada…","Endothelial cells express undetectable levels of surface erythropoietin receptor and erythropoietin does not promote angiogenesis in the rat cornea",2008,"","AACR","http://cancerres.aacrjournals.org/content/68/9_Supplement/1094.short","",127,"2019-06-10","","","","",,,,,0,0.00,0,6,11
0,"J Yan, V Vetvicka, Y Xia…","CELLULAR IMMUNOLOGY AND IMMUNE REGULATION-b-Glucan, a Specific Biologic Response Modifier That Uses Antibodies to Target Tumors for …",1999,"Journal of …","Baltimore, USA: Williams & Wilkins …","","",128,"2019-06-10","CITATION","","","",,,,,0,0.00,0,4,20
0,"K Romero, S Geuns-Meyer…","MEDI 372-Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase",2007,"ABSTRACTS …","… CHEMICAL SOC 1155 16TH ST, NW …","","",129,"2019-06-10","CITATION","","","",,,,,0,0.00,0,3,12
0,"MJ Giffin, EK Lobenhofer, K Cooke, T Raum, J Stevens…","BiTE® antibody constructs for the treatment of SCLC",2017,"","AACR","http://cancerres.aacrjournals.org/content/77/13_Supplement/3632.short","",130,"2019-06-10","","","","",,,,,0,0.00,0,6,2
0,"B Hodous, S Geuns-Meyer, V Patel, B Albrecht, V Cee…","Discovery of a potent, highly selective Tie-2 kinase inhibitor demonstrating in vivo efficacy, based on a novel pyridyl triazine scaffold.",2006,"","AACR","http://cancerres.aacrjournals.org/content/66/8_Supplement/1304.4.short","",131,"2019-06-10","","","","",,,,,0,0.00,0,6,13
0,"P Kaplan-Lefko, K Rex, J Moriguchi, Y Yang, Y Zhang…","AMG 458, a potent small molecule c-Met inhibitor, has significant anti-tumor activity in vivo",2008,"","AACR","http://cancerres.aacrjournals.org/content/68/9_Supplement/4976.short","",132,"2019-06-10","","","","",,,,,0,0.00,0,6,11
0,"CLZ de Zafra, F Fajardo, W Zhong, MJ Bernett…","Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T Cell-Recruiting Antibody Optimized for Cytotoxicity and Cytokine Release",2019,"Clinical Cancer …","AACR","http://clincancerres.aacrjournals.org/content/early/2019/03/27/1078-0432.CCR-18-2752.abstract","",133,"2019-06-10","","","","",,,,,0,0.00,0,5,1
0,"A Bakker, H Lebrec, B Lindl, G Adams, A Mardiros…","Generation and evaluation of an FLT3 CAR-T cell therapy for the treatment of acute myeloid leukemia",2018,"","AACR","http://cancerres.aacrjournals.org/content/78/13_Supplement/2559.short","",134,"2019-06-10","","","","",,,,,0,0.00,0,6,1
0,"PR Olivieri, SD Geuns-Meyer…","MEDI 370-Evolution of selective, potent, and orally bioavailable small molecule Tie-2 kinase inhibitors",2007,"ABSTRACTS …","… CHEMICAL SOC 1155 16TH ST, NW …","","",135,"2019-06-10","CITATION","","","",,,,,0,0.00,0,3,12
0,"B Falcon, H Hashizume, P Koumoutsakos, J Chou…","Abstract# 1996: Complementary and opposing effects of angiopoietin-1 and angiopoietin-2 inhibitors on tumor blood vessels and normalization",2009,"","AACR","http://cancerres.aacrjournals.org/content/69/9_Supplement/1996.short","",136,"2019-06-10","","","","",,,,,0,0.00,0,5,10
0,"JC Harmange, J Bready, A Coxon, T Demelfi, L Dipietro…","Design, synthesis, and evaluation of orally active benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors",2006,"","AACR","http://cancerres.aacrjournals.org/content/66/8_Supplement/1116.2.short","",137,"2019-06-10","","","","",,,,,0,0.00,0,6,13
1,"B Belmontes, SR Caenepeel, J Sun, D Chui, A Coxon…","The utilization of a human MCL1 knockin mouse suggests that reductions in B-cells and monocytes may serve as clinically relevant pharmacodynamic markers of …",2018,"","AACR","http://cancerres.aacrjournals.org/content/78/13_Supplement/2978.short","https://scholar.google.com/scholar?cites=12411034361950183548&as_sdt=800005&sciodt=0,15&hl=en",138,"2019-06-10","","","","",,,,,1,1.00,0,6,1
0,"S Caenepeel, A Coxon, Z Du, P Hughes…","Biomarkers and use of met inhibitor for treatment of cancer",2017,"US Patent App. 15 …","Google Patents","https://patents.google.com/patent/US20170182016A1/en","",139,"2019-06-10","","","","",,,,,0,0.00,0,5,2
